Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02119650
What this trial is testing

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation 76
Large-scale testing (Phase 3)UnknownNCT03533790
What this trial is testing

DEP-Ru Regimen as a Salvage Therapy for HLH

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Beijing Friendship Hospital 80
Large-scale testing (Phase 3)Ended earlyNCT02598297
What this trial is testing

Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.

Who this might be right for
Myelofibrosis With High Molecular Risk Mutations
Novartis Pharmaceuticals 49
Post-approval studies (Phase 4)UnknownNCT05447260
What this trial is testing

A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis

Who this might be right for
Myelofibrosis
Qilu Hospital of Shandong University 87
Not applicableUnknownNCT04361903
What this trial is testing

Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Azienda USL Toscana Nord Ovest 13
Testing effectiveness (Phase 2)Looking for participantsNCT07311746
What this trial is testing

Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia

Who this might be right for
T-cell Prolymphocytic LeukemiaRefractory T-Cell Prolymphocytic Leukemia
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT04492618
What this trial is testing

Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica

Who this might be right for
Necrobiosis Lipoidica
Aaron R. Mangold 12
Not applicableUnknownNCT04526223
What this trial is testing

Outcomes of MF Patients Exposure to Ruxolitinib During Transplantation

Who this might be right for
Time of Hematopoietic Reconstruction
xuna 30
Very early researchActive Not RecruitingNCT04906746
What this trial is testing

Ruxolitinib for Cancer Cachexia

Who this might be right for
Stage IV Non-small Cell Lung CancerCachexia
Tu Dan 10
Large-scale testing (Phase 3)Ended earlyNCT04934670
What this trial is testing

Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

Who this might be right for
Steroid-Refractory Acute Graft Versus Host Disease
Xenikos 12
Testing effectiveness (Phase 2)Study completedNCT03222609
What this trial is testing

A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis

Who this might be right for
Myelofibrosis (MF)
AbbVie 191
Testing effectiveness (Phase 2)Study completedNCT03011892
What this trial is testing

Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 307
Early research (Phase 1)Looking for participantsNCT07424222
What this trial is testing

Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)

Who this might be right for
Immune Effector Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Testing effectiveness (Phase 2)Study completedNCT02784496
What this trial is testing

Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis

Who this might be right for
Myelofibrosis
M.D. Anderson Cancer Center 8
Post-approval studies (Phase 4)UnknownNCT05021276
What this trial is testing

Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD

Who this might be right for
Safety and Efficacy
The First Affiliated Hospital of Soochow University 50
Large-scale testing (Phase 3)Ended earlyNCT02119663
What this trial is testing

Ruxolitinib in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Incyte Corporation 86
Testing effectiveness (Phase 2)Study completedNCT02158858
What this trial is testing

CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

Who this might be right for
MyelofibrosisLeukemia, Myelocytic, AcuteMyelodysplastic/Myeloproliferative Neoplasm+11 more
Constellation Pharmaceuticals 336
Large-scale testing (Phase 3)Ended earlyNCT04477993
What this trial is testing

Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2SARS-CoV2
Vanderson Geraldo Rocha 5
Testing effectiveness (Phase 2)Study completedNCT04629508
What this trial is testing

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

Who this might be right for
MyelofibrosisPolycythemia VeraThrombocythemia
Incyte Corporation 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT00044304
What this trial is testing

Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome

Who this might be right for
Eosinophilic Myeloid NeoplasmHypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 70
Next Page